Antigen tests are a quicker alternative to the more common molecular
PCR (polymerase chain reaction) testing kits. Although less
accurate, they can give results in minutes instead of the days
sometimes needed for PCR tests - a difference that could help better
trace cases and contain the pandemic.
About ten European nations are looking at antigen tests from either
U.S firm Abbott or Swiss rival Roche and its partner SD Biosensor,
the document shows, without naming the countries.
Both antigen and PCR tests need a nasal swab, but while PCR tests
detect genetic material in the virus, antigen tests look for
proteins on the virus's surface.
Countries around the world are jostling to secure supplies to help
tackle the COVID-19 pandemic, from tests and treatments to potential
vaccines. Earlier this month, the EU agreed to pay more than 1
billion euros ($1.2 billion) for supplies of antiviral drug
remdesivir, shortly before trial results that questioned its
effectiveness in treating COVID-19.
![](http://archives.lincolndailynews.com/2020/Oct/27/images/ads/current/bestfriends_sda_TIP_2020.png)
"The rapid antigen tests produced by Abbott and SD Biosensor/Roche
are the most considered options," said the document, published this
week on a little watched European Commission webpage.
It contained a debrief of a meeting of European health experts last
week in which governments exchanged information on rapid tests ahead
of new proposals on the matter from the Commission and a video
conference of EU leaders due on Thursday.
European Commission President Ursula von der Leyen said on Friday
the EU executive would direct 100 million euros ($118 million) to
buy up to 22 million antigen tests to meet EU countries' "immediate
needs".
Additional kits would be bought through a joint procurement scheme
led by the Commission, von der Leyen said, although it is not clear
whether EU governments will opt to buy together or on their own.
Half a dozen of the 27 EU states already use antigen tests.
Germany has said it has secured nine million testing kits a month
from Abbott, Roche and Siemens Healthineers, while the regional
state of Bavaria has ordered another 10 million. Italy announced
last week it was seeking to deploy 10 million tests in coming days.
SHORT SUPPLY?
The European rush to rapid tests comes as global demand has spiked
in recent months amid a surge in infections.
[to top of second column] |
![](http://archives.lincolndailynews.com/2020/Oct/27/images/ads/current/rohlfs_lda_072017.png)
The U.S. government said in August it had bought 150 million antigen tests from
Abbott for use through December.
Abbott said in October it had a monthly production capacity of 50 million
antigen tests. It was not immediately available for a comment for this story.
Roche says it can manufacture up to 40 million rapid testing kits each month and
aims to double its capacity by the end of the year "to meet the growing demands
of healthcare systems".
Among other large players, production from the likes of Siemens Healthineers and
Becton Dickinson could add millions of tests a month to global capacity, but
demand may temporarily exceed supply, Healthineers has warned.
At the pandemic's outset, many countries experienced shortages of PCR tests amid
sky-rocketing orders, and Roche has said demand is still far outstripping
supply.
Antigen tests will be one of the main topics EU leaders will discuss at a video
conference on Thursday, EU officials told Reuters.
That will follow proposals on Wednesday by the Commission to improve the bloc's
testing strategy and coordinate national rules on quarantines and contact
tracing, officials said.
Antigen tests are manufactured by dozens of other companies, too, but most have
lower or insufficiently tested accuracy compared with the main players.
![](http://archives.lincolndailynews.com/2020/Oct/27/images/ads/current/graue_sda_2016.png)
In clinical studies, Abbott's test has shown a sensitivity, or ability to
correctly spot positive cases, above 97%. It also has more than 98% specificity,
which helps to correctly identify people who are not infected, preventing
travellers from undergoing unnecessary quarantines.
Roche's test has a slightly lower sensitivity, but higher specificity.
($1 = 0.8466 euros)
(Reporting by Francesco Guarascio @fraguarascio and John Miller; additional
reporting by Emma Pinedo Gonzalez, Matthias Blamont and Emilio Parodi; Editing
by Mark Potter)
[© 2020 Thomson Reuters. All rights
reserved.] Copyright 2020 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |